Detectable mutations precede late myeloid neoplasia in aplastic anemia |
Feb 2021 |
Haematologica |
Aplastic Anemia |
Detection of paroxysmal nocturnal hemoglobinuria (PNH) in bone marrow aspirates |
Jan 2019 |
Semin Hematol |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study |
Jun 2023 |
Blood Advances |
Myelodysplastic Syndromes (MDS) |
Development of a target concentration intervention to individualize paroxysmal nocturnal hemoglobinuria treatment with pegcetacoplan |
Jul 2024 |
Annals of Hematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Diagnosis and classification of myelodysplastic syndromes |
Dec 2023 |
Blood |
Myelodysplastic Syndromes (MDS) |
Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP53 |
Dec 2023 |
Clinics in Laboratory Medicine |
Myelodysplastic Syndromes (MDS) |
Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North American Pediatric Aplastic Anemia Consortium |
Aug 2020 |
Pediatric Blood & Cancer |
Aplastic Anemia, Myelodysplastic Syndromes (MDS), Pediatric |
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies |
Oct 2023 |
Blood Advances |
Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN) |
Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes |
Nov 2019 |
American Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes |
Oct 2019 |
Blood Advances |
Myelodysplastic Syndromes (MDS) |